Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003109292 | SCV003792000 | pathogenic | Neurofibromatosis, type 1 | 2022-06-14 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the NF1 protein in which other variant(s) (p.Phe1863Leu) have been determined to be pathogenic (PMID: 27838393; Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. This variant has not been reported in the literature in individuals affected with NF1-related conditions. This variant results in the deletion of part of exon 37 and exons 38-46 of the NF1 gene. |